Fact sheet: Pictet Biotech

Fund information

Fund name
Pictet Biotech I dy GBP
Fund company manager
Pictet Asset Management (Europ
Fund type
SIB
Fund manager
Nathalie Flury
since 26/05/2016
Fund objective
The sub-fund seeks capital growth by investing at least two-thirds of its total assets in the shares of particularly innovative companies operating in medical biotechnology. The investment universe is not restricted to a specific geographical zone. However, given the particularly innovative nature of the pharmaceutical industry in North America and Europe, the vast majority of investments will be made in this zone.
Benchmark
MSCI World
Investment style
Growth
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

12.47 %

1 Year rank in sector

-

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 1.5 b

FE Risk score

221

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    92.5%
  • UK
    3.5%
  • Ireland
    1.2%
  • Money Market
    0.8%
  • Belgium
    0.7%
  • Health Care
    58.4%
  • Pharmaceuticals
    22.6%
  • Technology
    12.3%
  • Services
    5.9%
  • Money Market
    0.8%
  • US Equities
    92.5%
  • UK Equities
    3.5%
  • Irish Equities
    1.2%
  • Money Market
    0.8%
  • Belgian Equities
    0.7%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund3.56 %7.31 %12.47 %48.18 %139.64 %
Sector4.29 %4.59 %7.67 %20.6 %96.71 %
Rank within sector / / / / /
Quartile th th th th th th

Calendar performance

YTD-20172016201520142013
Fund18.31 %-8.61 %18.02 %31.77 %52.64 %
Sector15.62 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector / / / / /
Quartile th th th th th th

Risk statistics

Alpha7.05
Beta1.33
Sharpe0.56
Volatility22.85
Tracking error11.34
Information ratio0.74
R-Squared0.8

Price movement

52 week high659.11
52 week low485.39
Current bid price0
Current offer price0
Current mid price620.72

Holdings by region

  • 92.5% USA
  • 3.5% UK
  • 1.2% Ireland
  • 0.8% Money Market
  • 0.7% Belgium
  • 0.5% Netherlands
  • 0.5% Spain
  • 0.3% Switzerland

Holdings by sector

  • 58.4% Health Care
  • 22.6% Pharmaceuticals
  • 12.3% Technology
  • 5.9% Services
  • 0.8% Money Market

Holdings by asset type

  • 92.5% US Equities
  • 3.5% UK Equities
  • 1.2% Irish Equities
  • 0.8% Money Market
  • 0.7% Belgian Equities
  • 0.5% Dutch Equities
  • 0.5% Spanish Equities
  • 0.3% Swiss Equities

Individual holdings

  • 9.4% CELGENE CORP
  • 6.4% REGENERON PHARMACEUTICALS INC
  • 6% BIOGEN INC
  • 5.7% AMGEN INC
  • 5.7% GILEAD SCIENCES INC
  • 5% ALEXION PHARMACEUTICALS INC
  • 4.8% VERTEX PHARMACEUTICAL
  • 4.2% INCYTE CORP
  • 3.2% BIOMARIN PHARMACEUTICAL
  • 2.4% TESARO INC